Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials

Der Schmerz
M-A FitzcharlesWinfried Häuser

Abstract

In the absence of an ideal treatment for chronic pain associated with rheumatic diseases, there is interest in the potential effects of cannabinoid molecules, particularly in the context of global interest in the legalization of herbal cannabis for medicinal use. A systematic search until April 2015 was conducted in Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, www.cannabis-med.org and clinicaltrials.gov for randomized controlled trials with a study duration of at least 2 weeks and at least ten patients per treatment arm with herbal cannabis or pharmaceutical cannabinoid products in fibromyalgia syndrome (FMS), osteoarthritis (OA), chronic spinal pain, and rheumatoid arthritis (RA) pain. Outcomes were reduction of pain, sleep problems, fatigue and limitations of quality of life for efficacy, dropout rates due to adverse events for tolerability, and serious adverse events for safety. The methodology quality of the randomized controlled trials (RCTs) was evaluated by the Cochrane Risk of Bias Tool. Two RCTs of 2 and 4 weeks duration respectively with nabilone, including 71 FMS patients, one 4-week trial with nabilone, including 30 spinal pain patients, and one 5-week study with tetrahydrocannbinol/cannabidiol,...Continue Reading

References

Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M HerkenhamK C Rice
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·A M MalfaitM Feldmann
Aug 5, 2004·Psychotherapy and Psychosomatics·Boudewijn Van Houdenhove, Ulrich T Egle
Sep 2, 2004·Nature Reviews. Drug Discovery·Vincenzo Di MarzoLuciano De Petrocellis
Dec 17, 2004·International Clinical Psychopharmacology·Toshi A FurukawaNorio Watanabe
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Lee S Simon
Nov 3, 2007·The Journal of Pain : Official Journal of the American Pain Society·Ryan Quinlan SkrabekDaryl Perry
Dec 7, 2007·The Journal of Pain : Official Journal of the American Pain Society·Robert H DworkinStojan Zavisic
Oct 21, 2009·CNS & Neurological Disorders Drug Targets·Josée Guindon, Andrea G Hohmann
Nov 18, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jonathan Z LongBenjamin F Cravatt
Dec 17, 2009·Anesthesia and Analgesia·Mark A WareYoram Shir
Jul 16, 2010·Pain·R Andrew MooreUNKNOWN Cochrane Pain, Palliative and Supportive Care Systematic Review Group Editors
Mar 24, 2011·British Journal of Clinical Pharmacology·Mary E Lynch, Fiona Campbell
Nov 1, 2011·BMC Musculoskeletal Disorders·Nurcan UçeylerClaudia Sommer
Jun 26, 2012·Arthritis Care & Research·Peter A Ste-MarieYoram Shir
Jun 1, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Peter M Fayers, Ron D Hays
Jun 12, 2013·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Mary-Ann FitzcharlesUNKNOWN National Fibromyalgia Guideline Advisory Panel
Jan 18, 2014·Arthritis Research & Therapy·Winfried HäuserClaudia Sommer
Mar 5, 2014·Arthritis Care & Research·Mary-Ann FitzcharlesYoram Shir
Sep 3, 2014·The Journal of Rheumatology·Mary-Ann Fitzcharles, Shahin Jamal
Jan 13, 2015·Lancet Neurology·Nanna B FinnerupMark Wallace
Jun 24, 2015·JAMA : the Journal of the American Medical Association·Penny F WhitingJos Kleijnen

❮ Previous
Next ❯

Citations

Jan 27, 2016·Der Schmerz·L Radbruch, M Schäfer
Jun 9, 2016·Expert Opinion on Investigational Drugs·Kim Lawson
Nov 11, 2016·Current Rheumatology Reports·Mary-Ann Fitzcharles, Winfried Häuser
Nov 20, 2016·Clinical Pharmacology and Therapeutics·D KatzY Shoenfeld
Dec 19, 2017·Expert Opinion on Emerging Drugs·Fabiola AtzeniPiercarlo Sarzi-Puttini
Jun 18, 2017·Medwave·Rubén F Allende-Salazar, Gabriel Rada
May 26, 2017·Anesthesia and Analgesia·Howard MengAnuj Bhatia
Jan 17, 2019·The Journal of Rheumatology·Mary-Ann FitzcharlesUNKNOWN Canadian Rheumatology Association
Jul 7, 2019·Clinical Rheumatology·Glen S HazlewoodMary-Ann Fitzcharles
Sep 22, 2019·Der Schmerz·Frank PetzkeUNKNOWN Ad-hoc-Kommission der Deutschen Schmerzgesellschaft „Cannabis in der Medizin“
Jun 13, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Andreas KieferHolger Reimann
May 31, 2020·Regional Anesthesia and Pain Medicine·Faraj W AbdallahRichard Brull
Feb 26, 2020·Neurosurgery·Teddy E KimWesley Hsu
Aug 24, 2018·International Orthopaedics·Shaun H MedinaR Frank Henn
Jul 25, 2017·International Journal of Rheumatic Diseases·Nicola BarrieNicholas Manolios
Jun 9, 2018·Der Schmerz·M Karst
Sep 13, 2019·Expert Review of Clinical Immunology·Piercarlo Sarzi-PuttiniWinfred Hauser
Jun 10, 2018·Nature Reviews. Rheumatology·Daphna Katz-TalmorYehuda Shoenfeld
Dec 14, 2018·Frontiers in Pharmacology·Sonja VučkovićMilica Prostran
Dec 12, 2019·Systematic Reviews·Misty PrattBrian Hutton
Jul 24, 2020·Orthopaedic Nursing·Roberta Dume, Emily Lammers
Oct 11, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Dermot P MaherRonald J Kulich
Jun 20, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Eva HochUNKNOWN CaPRis-Projektgruppe
Feb 6, 2020·BMC Complementary Medicine and Therapies·Nadia Montero-OleasDaniel Simancas-Racines
May 20, 2020·Frontiers in Pharmacology·Donovan A ArguetaKalpna Gupta
Dec 19, 2020·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Inna KurlyandchikJanet Schloss
Feb 23, 2019·Clinical Orthopaedics and Related Research·Jason M JenningsDouglas A Dennis
Oct 12, 2017·Deutsches Ärzteblatt International·Winfried HäuserFrank Petzke
Jan 7, 2021·International Journal of Rheumatic Diseases·Luke Daniel WilliamsonNicholas Manolios
Apr 10, 2018·Joint, Bone, Spine : Revue Du Rhumatisme·Serge Perrot, Anne-Priscille Trouvin
May 2, 2021·Reumatología clinica·Javier Rivera RedondoUNKNOWN en nombre del Panel de expertos
May 15, 2021·Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews·David G DeckeyJoshua S Bingham
Jul 1, 2021·Journal of Gerontological Nursing·Brooke PorterKeela Herr
Jul 2, 2021·Der Anaesthesist·Michael Schäfer, Sascha Tafelski
Jul 30, 2021·ImmunoTargets and Therapy·Valeria GiorgiPiercarlo Sarzi-Puttini
Jul 20, 2021·Brazilian Journal of Anesthesiology·Camila Pantoja-RuizDiego Rosselli
Sep 8, 2021·Orphanet Journal of Rare Diseases·Nicholas H B SchräderMarieke C Bolling

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.